Key facts
- Notable investors include Wuxi Jinkong Qiyuan Investment.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Heyousheng Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Heyousheng Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Heyousheng Biotechnology
Manufacturer of biotechnology solutions designed for research, development, and healthcare applications. The company offers biology tools, cell culture systems, diagnostic assay development, biopharmaceutical research support, and laboratory-grade consumables, enabling scientific institutions, medical organizations, and industrial biotechnology enterprises to advance experimental accuracy, improve diagnostic reliability, enhance therapeutic innovation, streamline laboratory workflows, and support large-scale research initiatives through comprehensive and adaptable biotechnological resources that can be applied across diverse fields requiring precision and consistency.
- Sector
- Healthcare
- HQ
- Wuxi, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Heyousheng Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Heyousheng Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Heyousheng Biotechnology in its N-PORT filings yet. We sweep new filings monthly.